-
TCRT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Alaunos Therapeutics (TCRT)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.68 mm | 1.68 mm | 1.68 mm | 1.68 mm | 1.68 mm | 1.68 mm |
Cash burn (monthly) | 260.33 k | 855.08 k | 383.33 k | 1.00 mm | 260.33 k | 980.33 k |
Cash used (since last report) | 1.32 mm | 4.34 mm | 1.95 mm | 5.08 mm | 1.32 mm | 4.98 mm |
Cash remaining | 360.26 k | -2.66 mm | -264.69 k | -3.40 mm | 360.26 k | -3.30 mm |
Runway (months of cash) | 1.4 | -3.1 | -0.7 | -3.4 | 1.4 | -3.4 |
13F holders | Current |
---|---|
Total holders | 33 |
Opened positions | 11 |
Closed positions | 4 |
Increased positions | 2 |
Reduced positions | 10 |
13F shares | Current |
---|---|
Total value | 161.39 mm |
Total shares | 15.94 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
White Rock Capital Management | 9.63 mm | $23.30 mm |
Hardie Robert D. | 6.24 mm | $0.00 |
BlackRock | 21.35 k | $40.68 mm |
Vanguard | 20.97 k | $39.85 mm |
Geode Capital Management | 15.22 k | $28.92 mm |
UBS UBS | 7.87 k | $14.99 mm |
C Citigroup | 1.60 k | $3.03 mm |
Tower Research Capital | 1.15 k | $2.19 mm |
MS Morgan Stanley | 1.05 k | $1.99 mm |
Advisor | 857.00 | $2.75 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec 24 | Jaime Vieser | Common Stock | Sell | Dispose S | No | No | 2 | 818 | 1.64 k | 25,894 |
31 Dec 24 | Jaime Vieser | Common Stock | Sell | Dispose S | No | No | 2.01 | 2,182 | 4.39 k | 26,712 |
14 Aug 24 | Groenewald Ferdinand | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.42 | 1,500 | 3.63 k | 1,500 |
14 Aug 24 | Melinda Lackey | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.42 | 1,500 | 3.63 k | 1,500 |
6 Jun 24 | Robert Hofmeister | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.03 | 12,800 | 13.18 k | 12,800 |
6 Jun 24 | Holger Weis | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.03 | 4,524 | 4.66 k | 4,524 |
6 Jun 24 | Holger Weis | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.03 | 19,200 | 19.78 k | 19,200 |